NCT05609734

Brief Summary

Abstract Purpose Patients with anticoagulation therapy has a higher risk of developing traumatic Intracranial Hemorrhage (tICH). Delayed Intracranial Hemorrhage (d-ICH) is a rarer clinical manifestation; however, the incidence varies from 0-9,6 % in other studies. Some studies have also questioned the clinical relevance of d-ICH, since the mortality and the need of neurosurgical intervention is reported to be very low. The aim of this study is to determine the incidence of d-ICH at Sundsvall Regional Hospital. Methods A retrospective observational study of patients with mTBI and oral anticoagulation therapy. Data from medical records and radiology registry in Sundsvall hospital for 29 months during 2018-2020 in Sundsvall identified 249 patients with an initial negative CT scan who performed a follow-up CT scan. Outcome measure was incidence of d-ICH.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
249

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2021

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 30, 2021

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

April 15, 2022

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

October 14, 2022

Completed
25 days until next milestone

First Posted

Study publicly available on registry

November 8, 2022

Completed
Last Updated

November 8, 2022

Status Verified

November 1, 2022

Enrollment Period

3 months

First QC Date

October 14, 2022

Last Update Submit

November 1, 2022

Conditions

Keywords

antithrombotic therapy

Outcome Measures

Primary Outcomes (1)

  • delayed traumatic intracranial hemorrhage

    Inclusion criteria was mTBI and pre-injury anticoagulation or SGA therapy. A secondary CT scan was performed 6 hours later, to detect a delayed intracranial hemorrhage.

    6 hours

Study Arms (2)

Patients with an delayed traumatic intracranial hemorrhage

A total of 249 control CTs was performed, where the initial CT was normal regarding tICH. In the initial assessments 1 case of d-ICH (0,41%) was found, but after second opinion this case (case 1, Table 1) was regarded as a pictorial artefact (Table 1). Hence, no d-ICH was found.

Other: no intervention, only observational retrospective study

Patients without an delayed traumatic intracranial hemorrhage

A total of 249 control CTs was performed, where the initial CT was normal regarding tICH. In the initial assessments 1 case of d-ICH (0,41%) was found, but after second opinion this case (case 1, Table 1) was regarded as a pictorial artefact (Table 1). Hence, no d-ICH was found.

Other: no intervention, only observational retrospective study

Interventions

no intervention, only observational retrospective study

Patients with an delayed traumatic intracranial hemorrhagePatients without an delayed traumatic intracranial hemorrhage

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

This is a retrospective observational study investing the incidence of d-ICH at Sundsvall Regional Hospital. Data was collected from 2018-01-01 - 2020-05-30, and all data collection followed a predetermined protocol. Data was collected by two persons. Starting from the hospital's radiology registry, all CT-scan referrals from emergency departments surgical section and acute surgical ward with a possible traumatic brain injury was read. Hereafter patients' journals were used to retrieve mechanism of injury, pre-injury medications, and arrival status.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sundsvall Hospital

Sundsvall, Sweden

Location

Biospecimen

Retention: SAMPLES WITHOUT DNA

CT scans, patient journals and bloodsample results, no bloodsamples were saved for further analysizes

MeSH Terms

Conditions

Intracranial Hemorrhage, TraumaticBrain Injuries, Traumatic

Condition Hierarchy (Ancestors)

Intracranial HemorrhagesCerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesCraniocerebral TraumaTrauma, Nervous SystemVascular DiseasesCardiovascular DiseasesWounds and InjuriesBrain Injuries

Study Officials

  • Yücel Cengiz, Ph.D. M.D.

    Umea University

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 14, 2022

First Posted

November 8, 2022

Study Start

January 1, 2021

Primary Completion

March 30, 2021

Study Completion

April 15, 2022

Last Updated

November 8, 2022

Record last verified: 2022-11

Data Sharing

IPD Sharing
Will not share

Locations